Spectral CT imaging of human osteoarthritic cartilage via quantitative assessment of glycosaminoglycan content using multiple contrast agents
Open Access
- 1 April 2021
- journal article
- conference paper
- Published by AIP Publishing in APL Bioengineering
- Vol. 5 (2) , 026101
Abstract
Detection of early osteoarthritis to stabilize or reverse the damage to articular cartilage would improve patient function, reduce disability, and limit the need for joint replacement. In this study, we investigated nondestructive photon-processing spectral computed tomography (CT) for the quantitative measurement of the glycosaminoglycan (GAG) content compared to destructive histological and biochemical assay techniques in normal and osteoarthritic tissues. Cartilage-bone cores from healthy bovine stifles were incubated in 50% ioxaglate (Hexabrix®) or 100% gadobenate dimeglumine (MultiHance®). A photon-processing spectral CT (MARS) scanner with a CdTe-Medipix3RX detector imaged samples. Calibration phantoms of ioxaglate and gadobenate dimeglumine were used to determine iodine and gadolinium concentrations from photon-processing spectral CT images to correlate with the GAG content measured using a dimethylmethylene blue assay. The zonal distribution of GAG was compared between photon-processing spectral CT images and histological sections. Furthermore, discrimination and quantification of GAG in osteoarthritic human tibial plateau tissue using the same contrast agents were demonstrated. Contrast agent concentrations were inversely related to the GAG content. The GAG concentration increased from 25 μg/ml (85 mg/ml iodine or 43 mg/ml gadolinium) in the superficial layer to 75 μg/ml (65 mg/ml iodine or 37 mg/ml gadolinium) in the deep layer of healthy bovine cartilage. Deep zone articular cartilage could be distinguished from subchondral bone by utilizing the material decomposition technique. Photon-processing spectral CT images correlated with histological sections in healthy and osteoarthritic tissues. Post-imaging material decomposition was able to quantify the GAG content and distribution throughout healthy and osteoarthritic cartilage using Hexabrix® and MultiHance® while differentiating the underlying subchondral bone.Keywords
Funding Information
- Arthritis New Zealand (R210)
- Royal Society of New Zealand Rutherford Discovery Fellowship (RDF-UOO1204)
- New Zealand Ministry of Business Innovation and Employment (MBIE-UOCX1404, MBIE-UOOX1407)
- Medical Technologies Centre of Research Excellence
This publication has 67 references indexed in Scilit:
- Relationship of Bone Mineral Density to Progression of Knee OsteoarthritisArthritis & Rheumatism, 2013
- In vivo comparison of delayed gadolinium-enhanced MRI of cartilage and delayed quantitative CT arthrography in imaging of articular cartilageOsteoarthritis and Cartilage, 2013
- Comparative digital cartilage histology for human and common osteoarthritis modelsOrthopedic Research and Reviews, 2013
- Toward quantifying the composition of soft tissues by spectral CT with Medipix3Medical Physics, 2012
- Knee replacementThe Lancet, 2012
- Nondestructive assessment of sGAG content and distribution in normal and degraded rat articular cartilage via EPIC-μCTOsteoarthritis and Cartilage, 2010
- Comparison of quantitative imaging of cartilage for osteoarthritis: T2, T1ρ, dGEMRIC and contrast-enhanced computed tomographyMagnetic Resonance Imaging, 2009
- Quantitative assessment of articular cartilage morphology via EPIC-μCTOsteoarthritis and Cartilage, 2009
- Analysis of cartilage matrix fixed charge density and three-dimensional morphology via contrast-enhanced microcomputed tomographyProceedings of the National Academy of Sciences, 2006
- MR imaging of osteochondral grafts and autologous chondrocyte implantationEuropean Radiology, 2006